EV Biologics, Inc. (OTCMKTS:YECO) Short Interest Update

EV Biologics, Inc. (OTCMKTS:YECO) saw a significant decrease in short interest in the month of February. As of February 15th, there was short interest totalling 100 shares, a decrease of 50.0% from the January 31st total of 200 shares. Based on an average trading volume of 17,300 shares, the short-interest ratio is presently 0.0 days.

EV Biologics Stock Performance

Shares of EV Biologics stock opened at $0.09 on Friday. EV Biologics has a fifty-two week low of $0.09 and a fifty-two week high of $0.99. The stock has a 50 day moving average of $0.12 and a 200 day moving average of $0.20.

EV Biologics Company Profile

EV Biologics, Inc, a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces.